Literature DB >> 28615729

Systemic lupus erythematosus: BAFF emerges from the genetic shadows.

William Stohl1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28615729     DOI: 10.1038/nrrheum.2017.99

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  10 in total

1.  Overexpression of the Cytokine BAFF and Autoimmunity Risk.

Authors:  Maristella Steri; Valeria Orrù; M Laura Idda; Maristella Pitzalis; Mauro Pala; Ilenia Zara; Carlo Sidore; Valeria Faà; Matteo Floris; Manila Deiana; Isadora Asunis; Eleonora Porcu; Antonella Mulas; Maria G Piras; Monia Lobina; Sandra Lai; Mara Marongiu; Valentina Serra; Michele Marongiu; Gabriella Sole; Fabio Busonero; Andrea Maschio; Roberto Cusano; Gianmauro Cuccuru; Francesca Deidda; Fausto Poddie; Gabriele Farina; Mariano Dei; Francesca Virdis; Stefania Olla; Maria A Satta; Mario Pani; Alessandro Delitala; Eleonora Cocco; Jessica Frau; Giancarlo Coghe; Lorena Lorefice; Giuseppe Fenu; Paola Ferrigno; Maria Ban; Nadia Barizzone; Maurizio Leone; Franca R Guerini; Matteo Piga; Davide Firinu; Ingrid Kockum; Izaura Lima Bomfim; Tomas Olsson; Lars Alfredsson; Ana Suarez; Patricia E Carreira; Maria J Castillo-Palma; Joseph H Marcus; Mauro Congia; Andrea Angius; Maurizio Melis; Antonio Gonzalez; Marta E Alarcón Riquelme; Berta M da Silva; Maurizio Marchini; Maria G Danieli; Stefano Del Giacco; Alessandro Mathieu; Antonello Pani; Stephen B Montgomery; Giulio Rosati; Jan Hillert; Stephen Sawcer; Sandra D'Alfonso; John A Todd; John Novembre; Gonçalo R Abecasis; Michael B Whalen; Maria G Marrosu; Alessandra Meloni; Serena Sanna; Myriam Gorospe; David Schlessinger; Edoardo Fiorillo; Magdalena Zoledziewska; Francesco Cucca
Journal:  N Engl J Med       Date:  2017-04-27       Impact factor: 91.245

2.  BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator.

Authors:  P A Moore; O Belvedere; A Orr; K Pieri; D W LaFleur; P Feng; D Soppet; M Charters; R Gentz; D Parmelee; Y Li; O Galperina; J Giri; V Roschke; B Nardelli; J Carrell; S Sosnovtseva; W Greenfield; S M Ruben; H S Olsen; J Fikes; D M Hilbert
Journal:  Science       Date:  1999-07-09       Impact factor: 47.728

3.  Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases.

Authors:  G S Cheema; V Roschke; D M Hilbert; W Stohl
Journal:  Arthritis Rheum       Date:  2001-06

4.  A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus.

Authors:  Richard Furie; Michelle Petri; Omid Zamani; Ricard Cervera; Daniel J Wallace; Dana Tegzová; Jorge Sanchez-Guerrero; Andreas Schwarting; Joan T Merrill; W Winn Chatham; William Stohl; Ellen M Ginzler; Douglas R Hough; Z John Zhong; William Freimuth; Ronald F van Vollenhoven
Journal:  Arthritis Rheum       Date:  2011-12

5.  Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial.

Authors:  Sandra V Navarra; Renato M Guzmán; Alberto E Gallacher; Stephen Hall; Roger A Levy; Renato E Jimenez; Edmund K-M Li; Mathew Thomas; Ho-Youn Kim; Manuel G León; Coman Tanasescu; Eugeny Nasonov; Joung-Liang Lan; Lilia Pineda; Z John Zhong; William Freimuth; Michelle A Petri
Journal:  Lancet       Date:  2011-02-04       Impact factor: 79.321

6.  The discovery and development of belimumab: the anti-BLyS-lupus connection.

Authors:  William Stohl; David M Hilbert
Journal:  Nat Biotechnol       Date:  2012-01-09       Impact factor: 54.908

7.  Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus.

Authors:  J Zhang; V Roschke; K P Baker; Z Wang; G S Alarcón; B J Fessler; H Bastian; R P Kimberly; T Zhou
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

8.  Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus.

Authors:  Michelle Petri; William Stohl; Winn Chatham; W Joseph McCune; Marc Chevrier; Jeff Ryel; Virginia Recta; John Zhong; William Freimuth
Journal:  Arthritis Rheum       Date:  2008-08

9.  Genome-wide association meta-analysis in Chinese and European individuals identifies ten new loci associated with systemic lupus erythematosus.

Authors:  David L Morris; Yujun Sheng; Yan Zhang; Timothy J Vyse; Yong-Fei Wang; Zhengwei Zhu; Philip Tombleson; Lingyan Chen; Deborah S Cunninghame Graham; James Bentham; Amy L Roberts; Ruoyan Chen; Xianbo Zuo; Tingyou Wang; Leilei Wen; Chao Yang; Lu Liu; Lulu Yang; Feng Li; Yuanbo Huang; Xianyong Yin; Sen Yang; Lars Rönnblom; Barbara G Fürnrohr; Reinhard E Voll; Georg Schett; Nathalie Costedoat-Chalumeau; Patrick M Gaffney; Yu Lung Lau; Xuejun Zhang; Wanling Yang; Yong Cui
Journal:  Nat Genet       Date:  2016-07-11       Impact factor: 38.330

10.  BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth.

Authors:  P Schneider; F MacKay; V Steiner; K Hofmann; J L Bodmer; N Holler; C Ambrose; P Lawton; S Bixler; H Acha-Orbea; D Valmori; P Romero; C Werner-Favre; R H Zubler; J L Browning; J Tschopp
Journal:  J Exp Med       Date:  1999-06-07       Impact factor: 14.307

  10 in total
  1 in total

1.  Analysis of Serum Interleukin (IL)-1β and IL-18 in Systemic Lupus Erythematosus.

Authors:  Rachel Mende; Fabien B Vincent; Rangi Kandane-Rathnayake; Rachel Koelmeyer; Emily Lin; Janet Chang; Alberta Y Hoi; Eric F Morand; James Harris; Tali Lang
Journal:  Front Immunol       Date:  2018-06-07       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.